DSIP
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation. Research indicates DSIP may promote delta-wave (slow-wave) sleep, modulate cortisol and ACTH levels, and exhibit stress-protective properties. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.
Reconstitution Steps
Draw 3.0 mL bacteriostatic water with a sterile syringe. EACH
Inject slowly down the vial wall; avoid foaming.
Gently swirl/roll until dissolved (do not shake).
Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
Protocol Overview
Concise summary of the once-daily regimen based on clinical trial designs.
Goal: Support healthy sleep architecture and stress modulation over time
Schedule: Daily subcutaneous injections for 4–8 weeks (extend to 12 weeks if desired).
Dose Range: 100–300 mcg daily with gradual titration; advanced up to 500 mcg.
Reconstitution: 3.0 mL per 5 mg vial (~1.67 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.
Dosing Protocol
Suggested daily titration approach reflecting clinical study parameters.
Start: 100 mcg daily; increase by ~50 mcg every 1–2 weeks as tolerated.
Target: 250–300 mcg daily by Weeks 4–8.
Frequency: Once per day (subcutaneous), typically before bedtime.
Cycle Length: 4–8 weeks; optional extension to 12 weeks with periodic breaks.
Timing: Evening administration preferred; rotate injection sites.
Storage Instructions
Proper storage preserves peptide quality.
Lyophilized: Store at 2–8 °C (35.6–46.4 °F); for long-term storage, −20 °C (−4 °F) is acceptable.
Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within ~30 days; avoid freeze–thaw cycles.
Allow vials to reach room temperature before opening to reduce condensation uptake.
Important Notes
Practical considerations for consistency and safety.
Use new sterile insulin syringes; dispose in a sharps container.
Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
Inject slowly; wait a few seconds before withdrawing the needle.
Document daily dose and site rotation to maintain consistency.
Some research suggests DSIP effects may persist for multiple nights after dosing, adjust frequency as needed.
How This Works
DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis.
Potential Benefits & Side Effects
Observations from preclinical and clinical literature.
May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality.
Research suggests potential stress-protective and anxiolytic-like effects.
Some studies indicate DSIP does not induce pharmacological tolerance with continued use.
Generally well tolerated in human studies; occasional mild injection-site reactions may occur with subcutaneous administration.
Limited long-term safety data; periodic breaks are recommended as a precaution.
Lifestyle Factors
Complementary strategies that may support therapeutic goals.
Maintain consistent sleep-wake schedules to reinforce circadian rhythms.
Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed.
Create a cool, dark, quiet sleep environment.
Incorporate regular physical activity, ideally earlier in the day.
Manage stress through relaxation techniques (meditation, deep breathing).
Injection Technique
General subcutaneous guidance from clinical best-practice resources.
Clean your hands and work on a clean surface.
Swab the vial’s rubber stopper and injection site with alcohol; allow to dry.
Draw the calculated dose into the insulin syringe, eliminating air bubbles.
Suitable SC injection areas include the abdomen (2 inches from navel), outer thighs, upper outer arms, or flank/hip area.
Pinch a fold of skin between thumb and forefinger; insert the needle at 45–90° into subcutaneous tissue.
Do not aspirate for subcutaneous injections; inject slowly and steadily.
After injection, release the pinched skin and withdraw the needle at the same angle.
Apply gentle pressure with a clean cotton or alcohol pad; do not rub vigorously.
Rotate sites systematically with each dose to prevent irritation or tissue damage.
Immediately dispose of the used syringe in a proper sharps container.
